Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 8.42 M5.79 M4.32 M4.35 M 22.88 M Research & development ———— — Operating income -92.65 M-17.86 M3.94 M-59.94 M -166.51 M Non-Operating Income, Total -45 K211 K43.84 M-34.24 M 9.77 M Interest expense, net of interest capitalized 3.51 M4.99 M6.24 M4.83 M 19.57 M Non-Operating Income, excl. Interest Expenses -3.55 M-4.78 M37.6 M-39.07 M -9.8 M Unusual income/expense 0000 0 Pretax income -92.65 M-17.86 M5.94 M-59.94 M -164.52 M Equity in earnings 11.8 M03 M— — Taxes 043 K0171 K 214 K Non-controlling/minority interest -32.2 M-18.97 M-18.74 M-26.32 M -96.22 M After tax other income/expense ———— — Net income before discontinued operations -92.65 M-17.91 M19.91 M-38.63 M -129.28 M Discontinued operations ———— — Net income -92.65 M-17.91 M19.91 M-38.63 M -129.28 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -65.08 M-3.63 M5.89 M48.96 M -13.86 M Basic earnings per share (Basic EPS) 115.042.24-96.68— — Diluted earnings per share (Diluted EPS) 115.042.24-96.68-29.96 -9.36 Average basic shares outstanding 1.13 M1.17 M1.19 M1.29 M — Diluted shares outstanding 1.13 M1.17 M154.18 M1.29 M — EBITDA -92.41 M-17.72 M4.08 M-59.72 M -165.77 M EBIT -92.65 M-17.86 M3.94 M-59.94 M -166.51 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 242 K143 K141 K220 K 746 K